Psychiatry as clinical neuroscience

Main Article Content

José Luis Jiménez-López https://orcid.org/0000-0002-9653-6541

Keywords

Neurosciences, Connectome, Neurobiology, Mental Disorders

Abstract

Abstract


For more than a century, psychiatry has established its clinical practice on syndrome-based descriptions grouped into exclusive diagnostic categories and on the prescription of psychotropic drugs aimed at modifying signs and symptoms, with etiological hypotheses formulated from different theoretical frameworks, ranging from psychoanalytic to neurobiological. Recent research from a neuroscientific theoretical framework suggests that different psychiatric illnesses are interconnected at different levels. The approach to mental disorders from this new perspective has generated more precise etiological hypotheses, has favored the development of initiatives that recommend a radical change in psychiatric taxonomy, and has oriented pharmacological research to other therapeutic targets. This article raises the possibility of psychiatry being positioned as a clinical neuroscience based on studies on brain connectivity as a substrate of mental functioning (Human Connectome Project), transdiagnostic nosological classification initiatives from a dimensional and spectral perspective (Research Domain Criteria and Hierarchical Taxonomy of Psychopathology) the new psychopharmacological nomenclature based on neurosciences and the findings in genomic association studies. The paradigm shift for the approach to mental disorders also includes the training of specialists in psychiatry, which is why the inclusion of neuroscience subjects in medical residency programs is recommended.

Abstract 54 | PDF (Spanish) Downloads 71

References

1. Binder DK, Schaller K, Clusmann H. The seminal contributions of Johann-Christian Reil to anatomy, physiology, and psychiatry. Neurosurgery. 2007;61(5):1091-6. doi: 10.1227/01.neu.0000303205.15489.23

2. Aftab A, Ryznar E. Conceptual and historical evolution of psychiatric nosology. Int Rev Psychiatry. 2021;33(5):486-99. doi: 10.1080/09540261.2020.1828306

3. Heckers S, Kendler KS. The evolution of Kraepelin's nosological principles. World Psychiatry. 2020;19(3):381-8. doi: 10.1002/wps.20774

4. Rybakowski J. A half-century of participant observation in psychiatry. Part III: psychopharmacology. Psychiatr Pol. 2020;54(5):845-64. doi: 10.12740/PP/126249

5. Zohar J, Levy DM. Neuroscience-based nomenclature of psychotropics: Progress report. Eur Neuropsychopharmacol. 2022;57:36-8. doi: 10.1016/j.euroneuro.2022.01.002

6. Keshavan MS, Michael Song SH, Zhang Y, et al. Neuroscience in pictures: 1. History of psychiatric neuroscience. Asian J Psychiatr. 2024;92:103869. doi: 10.1016/j.ajp.2023.103869

7. Alemán-Gómez Y, Griffa A, Houde JC, et al. A multi-scale probabilistic atlas of the human connectome. Sci Data. 2022;9(1):516. doi: 10.1038/s41597-022-01624-8

8. Ge J, Yang G, Han M, et al. Increasing diversity in connectomics with the Chinese Human Connectome Project. Nat Neurosci. 2023;26(1):163-72. doi: 10.1038/s41593-022-01215-1

9. Middlebrooks EH, Grewal SS. Brain connectomics. Neuroimaging Clin N Am. 2022;32(3):543-52. doi: 10.1016/j.nic.2022.04.002

10. Tozzi L, Anene ET, Gotlib IH, et al. Convergence, preliminary findings and future directions across the four human connectome projects investigating mood and anxiety disorders. Neuroimage. 2021;245:118694. doi: 10.1016/j.neuroimage.2021.118694

11. Morris SE, Sanislow CA, Pacheco J, et al. Revisiting the seven pillars of RDoC. BMC Med. 2022;20(1):220. doi: 10.1186/s12916-022-02414-0

12. Conway CC, Forbes MK, Forbush KT, et al. A Hierarchical taxonomy of psychopathology can transform mental health research. Perspect Psychol Sci. 2019;14(3):419-36. doi: 10.1177/1745691618810696

13. Grotzinger AD. Shared genetic architecture across psychiatric disorders. Psychol Med. 2021;51(13):2210-6. doi: 10.1017/S0033291721000829

14. Grünblatt E. Genetics of OCD and related disorders: searching for shared factors. Curr Top Behav Neurosci. 2021;49:1-16. doi: 10.1007/7854_2020_194

15. Hagenbeek FA, Hirzinger JS, Breunig S, et al. Maximizing the value of twin studies in health and behaviour. Nat Hum Behav. 2023;7(6):849-60. doi: 10.1038/s41562-023-01609-6

16. Imamura A, Morimoto Y, Ono S, et al. Genetic and environmental factors of schizophrenia and autism spectrum disorder: insights from twin studies. J Neural Transm. 2020;127(11):1501-15. doi: 10.1007/s00702-020-02188-w

17. Nelson BD, Perlman G, Hajcak G, et al. Familial risk for distress and fear disorders and emotional reactivity in adolescence: An event-related potential investigation. Psychol Med. 2015;45: 2545-56.

18. Weinberg A, Kotov R, Proudfit GH. Neural indicators of error processing in generalized anxiety disorder, obsessive-compulsive disorder, and major depressive disorder. J of Abnorm Psychol. 2015;124:172-85. doi: 10.1037/abn0000019

19. Martinez S, Ellis JD, Bergeria CL, et al. Treating opioid use disorder and opioid withdrawal in the context of fentanyl. Annu Rev Clin Psychol. 2025;21(1):221-49. doi: 10.1146/annurev-clinpsy-081423-023518

20. Kotov R, Cicero DC, Conway CC, et al. The hierarchical taxonomy of psychopathology (HiTOP) in psychiatric practice and research. Psychol Med. 2022;52(9):1666-78. doi: 10.1017/S0033291722001301

21. Podwalski P, Samochowiec J. Neuroscience-based nomenclature – a paradigm shift in the classification of psychiatric drugs. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2022;38(1):35-47. doi: 10.5114/fpn.2022.117700

22. Cortese S, Singh MK, Novins DK. The neuroscience-based nomenclature child & adolescent (NbN C&A) for psychotropic medications: innovation in progress. J Am Acad Child Adolesc Psychiatry. 2022;61(11):1317-8. doi: 10.1016/j.jaac.2022.06.002

23. Nagy Y. Epigenetics of stress and stress disorders. Academic Press, 2022. doi: 10.1016/C2019-0-03695-3

24. Van Calker D, Serchov T. The "missing heritability" problem in psychiatry: is the interaction of genetics, epigenetics and transposable elements a potential solution? Neurosci Biobehav Rev. 2021;126:23-42. doi: 10.1016/j.neubiorev.2021.03.019

25. Sanders SJ, Neale BM, Huang H, et al. Whole genome sequencing in psychiatric disorders: the WGSPD consortium. Nat Neurosci. 2018;21(7):1017. doi: 10.1038/s41593-018-0102-8

26. Leichsenring F, Steinert C, Ioannidis JPA. Toward a paradigm shift in treatment and research of mental disorders. Psychol Med. 2019;49(13):2111-7. doi: 10.1017/S0033291719002265

27. Steele JD, Paulus MP. Pragmatic neuroscience for clinical psychiatry. Br J Psychiatry. 2019;215(1):404-8. doi: 10.1192/bjp.2019.88

28. Borbély É, Simon M, Fuchs E, et al. Novel drug developmental strategies for treatment-resistant depression. Br J Pharmacol. 2022;179(6):1146-86. doi: 10.1111/bph.15753

29. Hawes DJ, Allen JL. A developmental psychopathology perspective on adverse childhood experiences (ACEs): introduction to the special issue. Res Child Adolesc Psychopathol. 2023;51(12):1715-23. doi: 10.1007/s10802-023-01100-w

30. Teicher MH, Gordon JB, Nemeroff CB. Recog¬nizing the importance of childhood maltreat¬ment as a critical factor in psychiatric diagnoses, treatment, research, prevention, and education. Mol Psychiatry. 2022;27:1331-8. doi: 10.1038/s41380-021-01367-9

31. Brauser D. APA Unveils Early Plans for The Next DSM. Medscape. 2025 June 02 Disponible en: https://www.medscape.com/viewarticle/apa-unveils-early-plans-next-dsm-2025a1000eu1?form=fpf

32. Dingle AD, Torres-Reveron A, Gil M, et al. Mind, brain, and behavior: an integrative approach to teaching neuroscience to medical students. Acad Psychiatry. 2019;43(6):639-43. doi: 10.1007/s40596-019-01079-x

33. Brown JC, Dainton-Howard H, Woodward J, et al. Time for brain medicine. J Neuropsychiatry Clin Neurosci. 2023;35(4):333-40. doi: 10.1176/appi.neuropsych.21120312